The German Breast Group (study group) and GBG Forschungs GmbH work hand in hand with the aim of continually improving the treatment of breast cancer and the quality of the therapy available on a global basis. In order to achieve this goal, we conduct research within the context of academically orientated clinical trials. We work closely with research-based pharmaceutical companies and combine the latest active substances – enabling us to recommend the most effective forms of therapy.
As an independent academic research institute, we implement clinical trials in phases I to IV. Our field of research covers neoadjuvant drug therapy, operative therapy, post-operative adjuvant therapy and chronic palliative therapy.
Under the menu item “Trials”, you will find information about ongoing trials as well as trials currently in the follow-up phase. In addition, our “Trial Archive” contains details of trials already completed.